Cartesian Therapeutics, Inc. (RNAC)
Market Open
6 May, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XBER $
10. 57
-1.87
-15.03%
$
294.01M Market Cap
- P/E Ratio
0% Div Yield
112,497 Volume
- Eps
$ 12.44
Previous Close Day Range
10.48 12.49
Year Range
8.85 41.87
Want to track RNAC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| RNAC Cartesian Therapeutics, Inc. 6 May 2025 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics, Inc. 5 Mar 2025 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics, Inc. 11 Nov 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics, Inc. 15 Aug 2024 | | - Cons. EPS | 0.54 EPS |
| RNAC Cartesian Therapeutics, Inc. 8 Aug 2024 | | - Cons. EPS | 0.54 EPS |
| RNAC Cartesian Therapeutics, Inc. 14 Jun 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics, Inc. 20 May 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics, Inc. 2 May 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics, Inc. 7 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics, Inc. 6 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics, Inc. 4 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics, Inc. 1 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics, Inc. 29 Feb 2024 | | - Cons. EPS | - EPS |
2025 © Marketlog. All Rights Reserved.
